Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately Respond to Traditional Corticosteroid Therapy
On October 21 at the 5th Joint Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS), results were presented from a survey conducted by NARCOMS which found that about one-third of patients experiencing MS relapses do not adequately respond to corticosteroid treatment. The survey included over 2,000 patients with MS who had experienced relapses and were treated with either intravenous (IV) or oral corticosteroids.
Soon, 3-year-old Tess Sullivan won’t be able to chew or swallow, and she will likely die between the ages of five and 10 due to a rare genetic disorder, the BBC reported.
Tess has Alexander disease, a terminal degenerative brain disorder that primarily affects children, and usually causes death within 10 years of the first symptoms.
MS Patient, Writer, Blog writer, Editor of Stu’s Views and MS Related News and Founder of the ‘MS Views and News’ organization
My name is Stuart Schlossman and I Have MS. Relapse Remitting to be more specific.
I live just outside of Fort Lauderdale, Florida. I have been married since 1988 to Patrice, and have two grown daughters and three grandchildren. When I am not resting I have three dogs that keep me busy and I volunteer as a co-facilitator for the National MS Society, as well as for MS Views and News.
By HENRY L. DAVIS
Blockages in veins that drain brain are cited
The first half of a study to determine whether blockages in the veins that drain the brain cause multiple sclerosis have brought encouraging results, University at Buffalo researchers said Wednesday.
More than half of multiple sclerosis patients in the study exhibited the blockages, indicating an association with the disease.
By MEGAN BROOKS
Women who suffer from migraine headaches appear to be at much higher risk of developing multiple sclerosis (MS) than women in the general population, according to research released in advance of the American Academy of Neurology Annual Meeting to be held in Toronto in April. However, it remains unclear whether migraine is a risk factor for developing MS or if it is a condition that occurs at the same time as MS.